SPY334.19+5.46 1.66%
DIA275.90+4.20 1.55%
IXIC11,117.53+203.96 1.87%

Morgan Stanley Initiates Coverage On 10x Genomics with Overweight Rating, Announces Price Target of $135

Morgan Stanley initiates coverage on 10x Genomics (NASDAQ:TXG) with a Overweight rating and announces Price Target of $135.

· 09/09/2020 06:02
Morgan Stanley initiates coverage on 10x Genomics (NASDAQ:TXG) with a Overweight rating and announces Price Target of $135.